1 – 7 of 7
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Association between pre-biologic T2-biomarker combinations and response to biologics in patients with severe asthma
(
- Contribution to journal › Article
- 2023
-
Mark
Impact of Inititing Biologics in Patients With Severe Asthma on Long-term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER): Data From the International Severe Asthma Registry
(
- Contribution to journal › Article
-
Mark
Biologics in severe asthma : A pragmatic approach for choosing the right treatment for the right patient
(
- Contribution to journal › Article
-
Mark
Comparative effectiveness of Anti-IL5 and Anti-IgE biologic classes in patients with severe asthma eligible for both
(
- Contribution to journal › Article
-
Mark
EUFOREA/EPOS2020 statement on the clinical considerations for CRSwNP care
2023) In Allergy: European Journal of Allergy and Clinical Immunology(
- Contribution to journal › Article
- 2022
-
Mark
Characterization of Patients in the International Severe Asthma Registry with High Steroid Exposure Who Did or Did Not Initiate Biologic Therapy
(
- Contribution to journal › Article
- 2019
-
Mark
EUFOREA consensus on biologics for CRSwNP with or without asthma
(
- Contribution to journal › Scientific review